Big Think hosted a panel discussion highlighting cutting-edge autism research as part of our Breakthroughs series, made possible by Pfizer.
This conversation features back-and-forth exchanges between top luminaries in the field, including
New drugs for patients may be on the horizon, but "early, intense" behavioral treatment remains "the very best intervention for autism."
Four out of five autism sufferers are male. Is something in men’s genes—or brain structure—causing the gap?
Autism isn’t on the rise: it’s just getting defined better, and diagnosed more.
Autism sufferers unquestionably have feelings. It’s processing those feelings—and reading them in others—that they struggle with.
Many kids are vaccinated at age two, the same age at which autism is often first noticed. But the “evidence” that one causes the other doesn't wash.
There is not a single gene that triggers autism, but more likely dozens of genes that enhance the risk of autism.
Big Think presents a conversation between top experts highlighting cutting-edge autism research.
The symptoms of autism are better understood than its causes; psychiatrists classify the disorder as having two major components: impaired social cognition and a tendency toward narrow interests and repetitive...